Exane BNP Paribas Downgrades GlaxoSmithKline (GSK) to Underperform

September 13, 2016 12:56 PM EDT
Get Alerts GSK Hot Sheet
Price: $38.72 -0.08%

Rating Summary:
    6 Buy, 10 Hold, 3 Sell

Rating Trend: Down Down

Today's Overall Ratings:
    Up: 30 | Down: 30 | New: 23
Trade GSK Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

Exane BNP Paribas downgraded GlaxoSmithKline (NYSE: GSK) from Neutral to Underperform.

For an analyst ratings summary and ratings history on GlaxoSmithKline click here. For more ratings news on GlaxoSmithKline click here.

Shares of GlaxoSmithKline closed at $43.30 yesterday.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Downgrades

Add Your Comment